| User's Publication |
|
21579
Khade OS, Sasidharan S, Jain A, Maradani BS, Chatterjee A, Gopal D, Ravi Kumar RK, Krishnakumar S, Pandey A, Janakiraman N, Elchuri SV, Gundimeda S.
Identification of dysregulation of sphingolipids in retinoblastoma using liquid chromatography-mass spectrometry.
Exp Eye Res
2024
109798
PubMed ID: 38246332
DOI: 10.1016/j.exer.2024.109798
|
|
18226
Maradani BS, Parameswaran S, Subramanian K.
Development and characterization of DNA aptamer against Retinoblastoma by Cell-SELEX
Sci Rep
2022
12(1):16178
PubMed ID: 36171412
DOI: 10.1038/s41598-022-20660-3
|
|
20647
Kakkassery V, Gemoll T, Kraemer MM, Sauer T, Tura A, Ranjbar M, Grisanti S, Joachim SC, Mergler S, Reinhard J.
Protein Profiling of WERI-RB1 and Etoposide-Resistant WERI-ETOR Reveals New Insights into Topoisomerase Inhibitor Resistance in Retinoblastoma.
Int J Mol Sci
2022
23(7)
PubMed ID: 35409416
DOI: 10.3390/ijms23074058
|
|
13082
Raguraman R, Parameswaran S, Kanwar JR, Vasudevan M, Chitipothu S, Kanwar RK, Krishnakumar S.
Gene expression profiling of tumor stroma interactions in retinoblastoma.
Exp Eye Res
2020
PubMed ID: 32585195
DOI: 10.1016/j.exer.2020.108067
|
|
13774
Ravishankar H, Mangani AS, Shankar MB, Joshi M, Devasena T, Parameswaran S, Subramaniam K.
Characterization of NCC-RbC-51, an RB cell line isolated from a metastatic site
Histochem Cell Biol
2020
153(2):101-109
PubMed ID: 31781967
DOI: 10.1007/s00418-019-01832-1
|
|
13939
Ravishankar H, Mangani AS, Phoebe Moses GL, Mani SP, Parameswaran S, Khetan V, Ganesan S, Krishnakumar S.
Serum exosomal miRNA as biomarkers for Retinoblastoma
Exp Eye Res
2020
108184
PubMed ID: 32795526
DOI: 10.1016/j.exer.2020.108184
|
|
12604
Athyala PK, Chitipothu S, Kanwar JR, Krishnakumar S, Narayanan J.
Synthesis of saporin-antibody conjugates for targeting EpCAM positive tumour cells
IET Nanobiotechnol
2019
13(1):90-99
PubMed ID: 30964044
DOI: 10.1049/iet-nbt.2018.5222
|
|
14637
Athyala PK, Kanwar JR, Chitipothu S, Kanwar RK, Krishnakumar S, Watson JP, Narayanan J.
Neocarzinostatin, Aptamer Conjugates for Targeting EpCAM-positive Tumor Cells
Anticancer Res
2017
37(7):3615-3629
PubMed ID: 28668853
DOI: 10.21873/anticanres.11732
|
|
9718
Jayashree B, Srimany A, Jayaraman S, Bhutra A, Janakiraman N, Chitipothu S, Krishnakumar S, Baddireddi LS, Elchuri S, Pradeep T.
Monitoring of changes in lipid profiles during PLK1 knockdown in cancer cells using DESI MS.
Anal Bioanal Chem
2016
408:5623-32
PubMed ID: 27277815
DOI: 10.1007/s00216-016-9665-y
|
|
9743
Nalini V, Deepa PR, Raguraman R, Khetan V, Reddy MA, Krishnakumar S.
Targeting HMGA2 in Retinoblastoma Cells in vitro Using the Aptamer Strategy.
Ocul Oncol Pathol
2016
2:262-269
PubMed ID: 27843907
DOI: 10.1159/000447300
|
|
10861
Targeting CD44, ABCG2 and CD133 markers using aptamers: in silico analysis of CD133 extracellular domain 2 and its aptamer
RSC Adv.
2016
6, 32115-32123
DOI: 10.1039/C5RA27072C
|
|
14143
John A, Umashankar V, Samdani A, Sangeetha M, Krishnakumar S, Deepa PR.
In Silico Structure Prediction of Human Fatty Acid Synthase-Dehydratase: A Plausible Model for Understanding Active Site Interactions
Bioinform Biol Insights
2016
10:143-54
PubMed ID: 27559295
DOI: 10.4137/BBI.S38317
|
|
14153
Subramanian N, Srimany A, Kanwar JR, Kanwar RK, Akilandeswari B, Rishi P, Khetan V, Vasudevan M, Pradeep T, Krishnakumar S.
Nucleolin-aptamer therapy in retinoblastoma: molecular changes and mass spectrometry-based imaging
Mol Ther Nucleic Acids
2016
5(8):e358
PubMed ID: 27574784
DOI: 10.1038/mtna.2016.70
|
|
7226
Subramanian N, Kanwar JR, Kanwar RK, Krishnakumar S.
Targeting Cancer Cells Using LNA-Modified Aptamer-siRNA Chimeras.
Nucleic Acid Ther
2015
25:317-22
PubMed ID: 26334953
DOI: 10.1089/nat.2015.0550
|
|
7342
Venkatesan N, Deepa PR, Khetan V, Krishnakumar S.
Computational and in vitro Investigation of miRNA-Gene Regulations in Retinoblastoma Pathogenesis: miRNA Mimics Strategy.
Bioinform Biol Insights
2015
9:89-101
PubMed ID: 25983556
DOI: 10.4137/BBI.S21742
|
|
7360
Sangeetha M, Deepa PR, Rishi P, Khetan V, Krishnakumar S.
Global gene deregulations in FASN silenced retinoblastoma cancer cells: molecular and clinico-pathological correlations.
J. Cell. Biochem.
2015
116:2676-94
PubMed ID: 25958981
DOI: 10.1002/jcb.25217
|
|
7515
Subramanian N, Kanwar JR, Athalya PK, Janakiraman N, Khetan V, Kanwar RK, Eluchuri S, Krishnakumar S.
EpCAM aptamer mediated cancer cell specific delivery of EpCAM siRNA using polymeric nanocomplex.
J. Biomed. Sci.
2015
22:4
PubMed ID: 25576037
DOI: 10.1186/s12929-014-0108-9
|
|
9419
Tatsuya Yunoki, Yoshiaki Tabuchi, Atsushi Hayashi, Takashi Kondo
BAG3 Protects Against Hyperthermic Stress by Modulating NF-κB and ERK Activities in Human Retinoblastoma Cells
Graefes Arch Clin Exp Ophthalmol
2015
253(3):399-407
PubMed ID: 25471019
DOI: 10.1007/s00417-014-2874-1
|
|
14313
Subramanian N, Kanwar JR, Kanwar RK, Krishnakumar S.
Blocking the maturation of OncomiRNAs using pri-miRNA-17∼92 aptamer in retinoblastoma
Nucleic Acid Ther
2015
25(1):47-52
PubMed ID: 25513843
DOI: 10.1089/nat.2014.0507
|
|
14389
Sreenivasan S, Krishnakumar S.
Synergistic Effect of Curcumin in Combination with Anticancer Agents in Human Retinoblastoma Cancer Cell Lines
Curr Eye Res
2015
40(11):1153-65
PubMed ID: 25495096
DOI: 10.3109/02713683.2014.987870
|
|
14986
Subramanian N, Kanwar JR, Kanwar RK, Sreemanthula J, Biswas J, Khetan V, Krishnakumar S.
EpCAM Aptamer-siRNA Chimera Targets and Regress Epithelial Cancer
PLoS One
2015
10(7):e0132407
PubMed ID: 26176230
DOI: 10.1371/journal.pone.0132407
|
|
15237
Srimany A, Jayashree B, Krishnakumar S, Elchuri S, Pradeep T.
Identification of effective substrates for the direct analysis of lipids from cell lines using desorption electrospray ionization mass spectrometry
Rapid Commun Mass Spectrom
2015
29(4):349-56
PubMed ID: 26406347
DOI: 10.1002/rcm.7111
|
|
13761
Venkatesan N, Krishnakumar S, Deepa PR, Deepa M, Khetan V, Reddy MA.
Molecular deregulation induced by silencing of the high mobility group protein A2 gene in retinoblastoma cells
Mol Vis
2012
18:2420-37
PubMed ID: 23077401
|
|
8007
Endo S, Yamato K, Hirai S, Moriwaki T, Fukuda K, Suzuki H, Abei M, Nakagawa I, Hyodo I.
Potent in vitro and in vivo antitumor effects of MDM2 inhibitor nutlin-3 in gastric cancer cells.
Cancer Sci.
2011
102:605-13
PubMed ID: 21205074
DOI: 10.1111/j.1349-7006.2010.01821.x
|
|
19029
Kanamori-Katayama M, Kaiho A, Ishizu Y, Okamura-Oho Y, Hino O, Abe M, Kishimoto T, Sekihara H, Nakamura Y, Suzuki H, Forrest AR, Hayashizaki Y.
LRRN4 and UPK3B are markers of primary mesothelial cells
PLoS One
2011
6(10):e25391
PubMed ID: 21984916
DOI: 10.1371/journal.pone.0025391
|
|
8620
Mikami-Terao Y, Akiyama M, Yuza Y, Yanagisawa T, Yamada O, Kawano T, Agawa M, Ida H, Yamada H.
Antitumor activity of TMPyP4 interacting G-quadruplex in retinoblastoma cell lines.
Exp. Eye Res.
2009
89:200-8
PubMed ID: 19328784
DOI: 10.1016/j.exer.2009.03.008
|
Back
Top
CELL BANK Website
